olicy/Version 01/16/12/2012 Page No Polict Name: …mmiyharyana.gov.in/Docs/Notifications/Guidelines_for... · Web viewThe Haryana Government/State Health Society has been delegating

Page 1 of 51

Guidelines

for purchases under

Consolidated User Fee Fund

Issued by:State Health Society, Haryana

27-12-2013

PURCHASES UNDER CONSOLIDATED USER FEE FUND

1.0 BACKGROUND :

Reference is made to the Government Order Memo No 20/98/2000-5HB-III dated 12-08-2003 and Memo No 3/78/92-HB-III dated 16-01-2004 & 22-01-04 vide which the Swasthya Kalyan Samitis were allowed to retain the user fee and utilise the retained amount for up gradation and modernising the health care services. Various guidelines have since been issued from time to time to guide the SKS to make rational utilisation of these funds. Most of the restrictions imposed earlier were with the intention of ensuring that sanctioned funds under State and NRHM funds are not left un-utilised because of flexibility of utilisation of the user money funds. In order to make improvement of the health facilities, the guidelines are revised.

2.0 SCOPE:-

These guidelines define the delegated powers of the authority to purchase various items required for improvement in health facilities including medicines and consumables at various health institutions. They also define the conditions under which purchase is permitted and specified to the maximum limits by following the prescribed purchase procedure. The powers described in this document would be able to guide all health administrative authorities (SKSs, PMO/SMOs and MOs) to make purchases and to incur other expenditures out of User fee in order to facilitate the improvement in the health institutions.

3.0 MERGER OF SPP, IPP AND USER FUNDS FOR VARIOUS PURCHASES

3.1 Justification: The merger of receipt under User charges, SPP and IPP is necessary To have an overall outlook of the finances available with an institution. To avoid difficulties being experienced in the maintenance of separate

accounts of these programmes. To avoid confusion with respect to purchase of similar items under different

heads and to avoid the purchases of medicines and consumables by different departments of hospital in respect of SPP, IPP and User funds. These items being of similar nature are not ordered as consolidated resulting in non supply and short supply.

To avoid overlapping in purchase of items, as currently, one department does not know what the other department is purchasing.

Page 2

3.2 Revised Proposal

Now onwards all user charges received from SPP, IPP and user funds may be merged in one account namely Consolidated User Charges fund and expenditure on all other items as specified may be incurred out of this fund as per delegated powers. However, State Budget and NRHM funds will remain separate to have proper supervision and accountability of expenditure under those accounts. There will be one store managed by one store in charge. For the purpose of accountability the reporting on number of all surgeries should be done.

4.0 REVISION OF POWERS:-

The Haryana Government/State Health Society has been delegating powers to lower level authorities under State budget, NRHM, SPP, IPP, User Fee from time to time, for purchases including local purchase under various programmes. The powers of local purchase delegated earlier need revision in view of increase in load of deliveries, OPD, IPD and surgeries, in the various health institutions. The essential items are either not supplied in time leading to stock outs or the rate contracts/approved sources are not available. The various guidelines issued under the User Charges from time to time, need to be revised. The powers for local purchase of medicines and consumables required to run these programmes at District and Sub District levels also need to be integrated in a single document.

4.1 Better Patient Care: It is envisaged from the very inception of the user money scheme that it should be used for providing better facilities to patients and attendants and improving patient care. Therefore this fund should be used for building of new counters for patient registration, Drug Dispensing, lab sample collection & report distribution; reducing patient wait time; increasing the seating capacities in patient waiting areas; providing free medicines and free surgeries to all; better surgical services; ensuring clean linen, maintenance etc as enumerated in schedule A

4.2 Consolidated User Fee Funds: Henceforth, all funds under IPP, SPP and User charges would be merged into a Consolidated User Fee Fund and all expenditure would now be made from this fund.

i. The guidelines below define the maximum power of various health authorities to incur expenditure from this fund:

Page 3

SN Level Of Institution Authority to whom power delegated

Amount Remarks

1 District Hospitals of 200 bedded and above including Panchkula.

SKS (Hospital) Up to 20,00,000/- per month

Local Purchase of items specified in schedule A as per prescribed purchase procedure in section 5

2 District Hospitals of 200 bedded and above including Panchkula

Chairperson SKS (Hospital)

Up to 1,00,000/- per month

-do-

3 District Hospitals of 100 but below 200 bedded including GH Bahadurgarh and GH 10 Gurgaon

SKS(Hospital) Up to 10,00,000/- per month

-do-

4 District Hospitals of 100 but below 200 bedded including GH Bahadurgarh and GH 10 Gurgaon

Chairperson SKS (Hospital)


-do-

5 Other Hospitals SKS(Hospital) Up to 7,00,000/- per month

-do-

6 Other Hospitals Chairperson SKS(Hospital)

Up to 75,000/- per month

-do-

7 CHC/UHC/Polyclinic

SKS (CHC) UHC/Polyclinic


-do-

8 CHC/UHC/Polyclinic

Chairperson SKS (CHC)/ UHC/Polyclinic


-do-

9 PHC/Dispensary SKS (PHC) & SKS Dispensary


-do-

10 PHC/Dispensary Chairperson SKS (PHC) & SKS Dispensary


-do-

*CHC: Community Health Center, *UHC: Urban Health Center,

*PHC: Primary Health Center,

Page 4

ii. The expenditure can be incurred for items specified in Annexure A to these guidelines.

iii. Each SKS should ensure that first funds available under State/NRHM budget must be utilised before incurring expenditure under the Consolidated User Fee Fund.

iv. The Chairperson of the Executive Committee of the District Health and Family Welfare Society may transfer the funds from one health facility to another wherever required in the district.

v. The Chairperson of the Executive Committee of State Health Society may be empowered for transfer of user fee funds as deemed necessary from the district health institutions to the HQs for the purpose of meeting deficiencies in services as and when required. The funds thus collected should also be utilised for the strengthening of the Hospital Management Division and Hospital Planning Division under the DGHS.

vi. The Chairperson of the Executive Committee of State Health Society may be empowered to transfer user fee funds from institution(s) located in one district to another district with proper justification.

vii. The PMO/SMO/MS would be competent to invite the tender for making improvement in hospital services to the patients.

viii. In case the funds are absolutely required for items falling under the heads of NRHM Budget (like those defined in Schedule B) and are not specified in Schedule A for running the health facilities efficiently, the SKS may allow to use consolidated user fee funds subject to adjustment later on. However the funds have to be recouped by the end of the Financial Year.

ix. The Local Purchase of drugs and consumables should be done only after computer generated. Non Availability Certificate (NAC) from the warehouse for items to be provided from warehouse. The NAC once obtained should be valid till the date of next indent. In case of part supply the document showing part supply as compared to the indent should serve as NAC. For drugs not to be supplied by warehouse and approved for Local purchase (as in Schedule D and E) no NAC is required.

x. The earlier restriction of purchase of medicines only for 1 week is henceforth removed. The SKS committee must plan the purchase of drugs and consumables according to requirement. For those items which are to be indented from warehouse in case of non supply (after obtaining NAC) and in case of part supply, the purchase should be made for the period till next indent. For items which are not to be supplied from warehouse the purchases should be rationalised after examining the required quantity, avoiding overstocking and also considering the economy of scale.

Page 5

xi. If the meeting of SKS is not feasible immediately, the PMO/SMO/MS would also be authorized to make local purchase to the extent the of financial power delegation made subject to final approval of SKS in the next meeting.

xii. The Facility in charges should ensure that Drugs and consumables should be purchased keeping in view the actual requirement with proper justification; Press tenders/ quotations where required should be invited; regular meetings of SKS should be convened wherein requirements and expenditure got approved; the doctors of the hospitals must be consulted and transparency maintained.

xiii. There are certain items which are required for a longer period of time. In order to get the benefit of scale it is envisaged that they should be purchased at one go. However since the utilization of these items would be spread over a longer period, it would not be financially appropriate to book the entire expenditure in the month in which they are purchased. Therefore the expenditure would be amortized by spreading the total expenditure over a period of time for which it is proposed to be utilized. Taking the example of X-ray films, if total monthly requirement of X-ray films is of Rs 1,00,000 and the total yearly requirement would be Rs. 12,00,000. If the X-ray films are purchased for the entire year in month of January, then instead of booking the whole expenditure on X-ray films i.e. Rs 12,00,000 in the month of January, rather it should be amortized/spread over 12 months at the rate of Rs 1,00,000 per month. Even while the full payment to the vender would be made in the January itself. As a result of this, the power of SKS committee would be available for purchase of other items for the month of January i.e. Rs 19,00,000 will be available out of the total power of Rs 20,00,000 if amortisation is done. If amortisation is not done then the entire amount of Rs 12,00,000 would be booked in January and balance of Rs 8,00,000 only will be available to make purchases of other items during January. The corresponding power of every month for remaining months of the year would be reduced to Rs 19,00,000. This system will in respect of other purchases for a longer period of time.

5.0 REPORTING OF EXPENDITURE:

I. Each District Accounts Manager should consolidate the monthly receipt and expenditure district-wise and submit to MD NRHM and DGHS by 15th

of next month.

Page 6

II. The detail of expenditures under all heads including detail of each item (like all drugs and consumables) should be entered on Drug portal as and when these are purchased which will be studied thoroughly to find major expenditures occurring at all districts. It will help to reach at the decision that which additional budget head needs to be sanctioned at state level and which additional drug and consumable needs to be supplied from warehouse.

6.0 PURCHASE PROCEDURE: Items to be purchased should be further categorized into two types:-

6.1 For items other than Drug and consumable:- They should first be purchased from approved sources. If not available on approved sources then purchase procedure as specified in table should be followed.

6.2 For Drugs and consumables the following procedure should be followed:-

6.2.1 Drugs and consumables exclusively for local purchase:

Purchase may be made for appropriate period (3 months to 1 year) depending on requirement, as per the procedure laid out below:The purchases are of two kinds viz. Recurring and non-recurring.

a) Recurring Items:- These are items which are required repeatedly during the year.

In case of recurring items, tender would need to be invited where the estimated annual demand for each item is more than one Lac. In case the estimated annual demand is less than Rs. 1 lac, then purchases can be made by inviting quotations. The tender/quotations thus finalized should be valid for a period of 1 year from the date of finalization, so that repeated orders can be placed on the vendor, during the period of validity.

b) Non-Recurring Items:- These are items which are required on a particular occasion.

In case of non-recurring items purchase is to be made by way of press tenders, if on a particular occasion value of an item is more than Rs1 lac, otherwise (for item below 1 lac) purchases will be made through quotations.

For, the recurring items, the purchasing authority at district or hospital level should estimate the demand of each item at the beginning of each financial year and if the annual value of item exceeds Rs 1 lac then tender should be

Page 7

invited and supplier and rate fixed. In case the annual demand is estimated to be less than 1 lac then quotations should be called as per procedure.

6.2.2 Drugs and consumables for which rate contract is still pending:

To make local purchases for the items whose RC is still pending, local purchase can be made at the district and hospital level as per local purchase guidelines as mentioned supra, till such time as rate contracts are finalized and information is available on Web Portal that the supply of such items will be made from the warehouses on a particular date.

6.2.3 Non supply or part supply from warehouse:

I. Drugs and consumables which are on rate contract and orders have been placed but supply is awaited at the warehouse : or

II. Drugs and consumables have not been supplied as per indent received from each Health Facility due to limited stock in warehouse : or

III. Drugs and consumables which have not been issued to the Health Facilities due to non-availability of the same in the warehouses :

In the all the conditions referred in 3 (I), 3 (II) and 3 (III), period of local purchase in such cases should be from date of non supply of such items (against indent placed with the warehouse) till the due date of next indent. In case such drugs and consumables are not available in Warehouses even on the date of next indent further repeat order can be made after recording proper justification of requirement of items.

The procedure for local purchase in such cases should be only through quotations irrespective of the amount involved (i.e even if the amount exceeds Rs. 1 lac/item) so that uninterrupted supply chain can be maintained by making local purchases.

Page 8

6.3 Mode of purchase:

SNO. MODE EXISTING POWERS

REVISED POWERS

1Without quotation Rs 1,000/- per

occasionMaximum upto Rs 2500/- per occasion

In case of ortho implants Maximum upto Rs 10,000/- per occasion

2With Quotation Rs 50,000/- per

occasionMaximum upto Rs 1,00,000/- per occasion

3 TenderAbove 50,000/- per occasion by Civil Surgeon.

Above Rs 1,00,000/- per occasion by Civil Surgeon for

PHCs,CHCs,UHC,Polyclinic,UD and Sub Centers

PMO/MS/SMO for Hospitals

* Any expenditure required to be made which is beyond Rs 20,00,000/- per month should be incurred after prior approval of Chairperson of State Health Society

7.0 REVISION OF ESSENTIAL DRUG LIST (EDL) OF HARYANA AND CATEGORISATION BASED ON ITS LEVEL OF PURCHASE:

The Committee under the DGHS Haryana, in its meeting on 19-12-2013 revised the EDL and deleted 90 number of medicines and 113 components in existing EDL.

Now the revised EDL contains 283 drugs and 427 components (Components means different dosage forms and strengths of the same salt), categorized them into 3 parts:

EDL-RC (Schedule C) EDL-Non-RC. (Schedule D) Non-EDL Drugs. List of drugs from Standard Treatment Guidelines (STG).

(Schedule E)

The categorization is also done on the basis of level of purchase.

a) State Level Purchase List: These drugs have a Rate Contract (RC) and would be purchased at state level and supplied through the warehouses. List attached as Schedule C.

Page 9

b) District/Institution Level Purchase List:

i) EDL-RC Drugs: Non-availability of medicines in warehouse as per EDL-RC drugs may be purchased after getting Non Availability Certificate (NAC).

ii) EDL-Non-RC Drugs: List of EDL medicines approved for local Purchase attached as Schedule D. These drugs are contained in the EDL and do not have an RC therefore should be purchased locally. These are essential drugs which are required in small quantities in emergencies or/and in uncommon conditions. These are essential drugs which should be purchased and made available in adequate quantities at all times.

iii) Non-EDL drugs:

a) These are drugs drawn from Standard Treatment Guidelines (STG) which may be purchased locally as they are required in small quantities and in uncommon conditions Schedule E.

b) In addition to the above lists, the local purchase may also be done by SKS with proper justification recorded in its minutes for any medicines or consumables required for treatment of any particular patient.

8.0 SUPERSESSION OF ALL EARLIER GUIDELINES:

These guidelines would supersede all instructions/ guidelines/clarifications issued from time to time, under user fee, SPP and IPP programmes.

Page 10

9.0 SCHEDULES AND ANNEXURES

SCHEDULE A

SNO Activity/ Item Remarks1 Lab Articles Including reagents and kits2 POP Bandages for Emergency3 Ortho Implants The implants must be of Indian make4 Dental Articles5 X Ray/ USG Films

6 Printing & Stationary itemsLike printing of OPD cards, Indoor files etc.

7 Items required in Mortuary8 Medical Gases

9Contractual Remuneration to the employees

Only with respect to staff sanctioned by HQ (MD NRHM/DGHS)

10 For Infrastructure improvements

This can include electrical fittings and maintaining public health facilities excluding major civil works. This expenditure may be incurred only after expiry of AMG and with prior approval of MD, NRHM/DGHS

11 Items required for Sanitation

12Maintenance/ Repair/AMC/CMC of equipments

Include computer, machinery like lifts, generators, biomedical equipments, Dental chair/ units etc. AMC/CMC should only be done if funds are not available from regular sources of state

13 Linen, mattress, beds and Blankets14 Purchases under SPP15 Purchases under IPP16 Repair and maintenance and

upkeep of health institutions17 Drugs and consumables as per

defined conditions in Section 6.018 Water/ electricity/ Landline

telephone BillsIn case of non availability of funds under state budget.

19 Contractual Remuneration to Specialist where found deficient

Only with prior approval of HQ (MD NRHM/ DGHS)

20 Improvement of Boarding lodging arrangement for patients and attendants

Page 11

21 Contracting out/outsourcing services like cleaning, laundry, cooking, diagnostic services

These services only with prior approval of MD/DGHS if no funds are available under state/NRHM.

22 POL for Gen sets23 Drinking water facilities24 Surgical and Examination

instrumentslike Dental instruments

25 Minor equipments Costing less than Rs 10,000 per equipment

26 Purchases for Biomedical Waste Managment

27 Other items With prior approval of MD NRHM/DGHS

*Imp. User Fee Fund should not be spent on items otherwise to be procured from NRHM or State budget. NRHM budget to be spent at institute level should be deposited and maintained in separate account and expenditure should be incurred by following these guidelines unless otherwise directed in any case.

Page 12

Schedule B

1. On the basis of examination of expenditure of District Hospital, the user fee is being spent on items for which the budget was specifically provided by NRHM for e.g. on free delivery , and free caesarian, free diagnostics to Antenatal cases. In future however the money may continued to be spent for these activities from user fee fund if required but should be replenished from the respective programme fund within that financial year.

a. Jannni Shishu Suraksha Karyakaram (JSSK) Normal Delivery and Caesarean Section.

b. Eye Surgeriesc. Cleft Lip; Cleft Palate; Tongue Tie operations.d. Any Other Scheme of the State & GOI

Page 13

Schedule - C

Revised Haryana Essential Drug List with Rate Contract (To be purchased at state level)

*Total Drugs = 242 *Total Components = 375

* All drugs to be dispensed in OPD will be made available in IPD as and when required.

* All drugs in OPD, IPD should be made available in OT as and when required.

* The column IPD combines the drugs to be made available at different work stations of the hospital like wards, Injection Room, Labour Room, Emergency department, ICU, SNCU, Minor OT or any other.

Sr. No.

Comp.Sr.No

MedicinesDosage Forms

Strength Category Usage

GH CHCPHC/UD

Sub centre

OPD IPD OT

1. ANAESTHETICS 1.1 General anesthetics and oxygen

1 1 Halothane Inhalation

3% to 5% in oxygen/Nitrous Oxide. Maint 0.5-1%,(250ml)

GH OT

2 2 KetamineInjection, (as hydrochloride)

50 mg /ml,10 ml vial

GH CHC OT

3 3Thiopentone

Injection (sodium) Powder

0.5 g GH OT

4 4 Midazolam Injection 1 mg/ml GH CHC OT

5 5 Propofol Injection1% vial (10mg/ml ,10 ml vial)

GH OT

6 6

*Isoflurane *Purchase in small quantity & prescription has to be monitored

Inhalation 100 ml GH OT

Page 14

7 7 Fentanyl Injection25 mcg/ml (2ml)

GH OT

8 8Sevoflurane

Inhalation 250 ml GH OT

1.2 Local anaesthetics

9 9

Bupivacaine For epidural & local anesthesia

Injection (hydrochloride)

0.5% 5 ml ampoule

GH CHC OT

10 10

Bupivacaine heavy 5 mg with Dextrose Monohydrate 80 mg/ml for Spinal Anaesthesia

Injection5 mg + 80 mg/ml,4 ml ampoule

GH CHC OT

11

11 Lignocaine Hydrochloride

Jelly sterile 2%, 30 gm GH CHC PHC IPD 12 Jelly sterile 5%, 20 gm GH CHC PHC IPD

13 Injection2%, 30 ml vial

GH CHC PHCSub centre

IPD

12 14

Lignocaine Hydrochloride + Adrenaline

Injection

2% + Adrenaline 1:80,000, 30 ml vial

GH CHC PHC IPD

1.3 Preoperative medication and sedation for short-term procedures

13

15

Atropine.

Injection (sulphate)

0.5 mg/ml, 1 ml ampoule

GH CHC PHC IPD OT

16Injection (sulphate)

0.5 mg/ml, 20 ml ampoule

GH IPD OT

14 17Glycopyrolate

Injection 0.2 mg/ml 1 ml ampoule

GH IPD

15 18 Diazepam Injection 5 mg/ml, 2 ml ampoule

GH CHC PHC IPD

2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES

Page 15

(NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS IN RHEUMATOID DISORDERS (DMARDs)

2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)

16

19

Diclofenac

Tablet (sodium)

50 mg GH CHC PHCSub centre

OPD

20 Injection25 mg/ml, 3 ml Ampoule

GH CHC PHC IPD

21 Gel 1% GH CHC PHC OPD

17 22

Diclofenac Sodium 50 mg + Paracetamol 325 mg Tab

Tablet50 mg + 325 mg

GH CHC PHC OPD

1823

Ibuprofen Tablet 200 mg GH CHC PHC OPD

24 Tablet 400 mg GH CHC PHC OPD

19 25Thiocolchicoside

Tablet 4mg GH CHC OPD

20

26

Paracetamol

Tablet 500 mg GH CHC PHCSub centre

OPD

27 Suspension125 mg/5ml,60 ml


OPD

28 Injection150 mg/ml,2 ml ampoule

GH CHC PHC IPD

29 Drops 150 mg/ml GH CHC PHC OPD

21 30Aceclofenac 100mg

Tablet 100 mg GH CHC PHC OPD

2.2 Opioid analgesics

22

31 Morphine Sulphate/Hydrochloride *Purchase in small quantity & prescription has to be monitored

Tablet 10 mg GH IPD

32 Injection10 mg/ml, 1ml ampoule

GH IPD

23

33Tramadol Hydrochloride

Tablet 50 mg GH CHC OPD

34 Injection50 mg/ml 2 ml ampoule

GH CHC IPD

Page 16

24 35

*Pentazocine lactate *Purchase in small quantity & prescription has to be monitored

Injection25 mg/ml, 1 ml Ampoule

GH CHC PHC IPD

25 36

*Pethidine Hydrochloride *Purchase in small quantity & prescription has to be monitored

Injection50 mg/ml,1 ml ampoule

GH IPD

2.4Disease modifying agents used in rheumatoid disorders (DMARDs)

26 37 Hydroxy Chloroquine

Tablet (Sulfate)

200 mg GH CHC OPD

27 38 Sulfasalazine

Tablet 500 mg GH OPD

28 39Methotraxate

Tablet 2.5 mg GH OPD

3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS

29

40

Cetrizine


41 Suspension5 mg/ml,60 ml


OPD

42 Drops 10mg/ml GH OPD

30 43Chlorpheniramine

Tablet (hydrogen maleate)


OPD

31 44Pheniramine maleate

Injection22.75 mg/ml,2 ml


IPD

3245 Hydroxyzin

eTablet 10 mg GH CHC PHC OPD


33 47Dexamethasone

Injection (disodium)

4 mg/ml,2 ml ampoule


IPD

34 48 Hydrocortisone

Powder for injection (sodium

100 mg vial GH CHC PHC Sub centre

IPD

Page 17

succinate)

35

49 Prednisolone

Tablet 10 mg GH CHC PHC OPD 50 Tablet 20 mg GH CHC PHC OPD

51 Suspension5mg/5ml, 60 ml

GH OPD

There is no evidence for complete clinical similarity between prednisolone and dexamethasone at high doses

4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING 4.2 Specific

36 52

Antisnake venom(polyvalent solution)

Injection 10 ml vial GH CHC PHC IPD

37 53

Antisnake venom (polyvalent solution)(Dry Powder)

Injection 10 ml vial GH CHC PHC IPD

5. ANTICONVULSANTS/ANTIEPILEPTICS

3854

Carbamazepine

Tablet 100 mg, GH CHC PHC OPD 55 Tablet 200 mg GH CHC PHC OPD 56 Suspension 20 mg/ml GH CHC PHC OPD

3957

LorazepamInjection

2 mg/ml 2 ml ampoule

GH CHC IPD

58 Tablet 1 mg GH CHC OPD 59 Tablet 2 mg GH CHC OPD

40 60

Magnesium sulphate For use in eclampsia and severe pre-eclampsia and not for other convulsant disorders

Injection500mg/ml,1ml ampoule


IPD

4161

Phenobarbitone

Tablet 30 mg GH CHC PHC OPD 62 Tablet 60 mg GH CHC PHC OPD 63 Suspension 20 mg/ 5 GH CHC PHC OPD

Page 18

ml

64 Injection200 mg/ ml

GH CHC PHC IPD

42

65

Phenytoin

Tablet (sodium)

100 mg GH CHC PHC OPD

66 Suspension100 mg/ 5 ml

GH CHC PHC OPD

67Injection (sodium)

50 mg/ml GH CHC PHC IPD

43

68 Sodium valproate/Valproic acid

Enteric coated tablet (sodium)

200 mg GH CHC OPD

69Enteric coated tablet (sodium)

500 mg GH OPD

44

70 Divaloprex Sodium equivalent to Valproic Acid


71 Tablet 500 mg GH OPD

6. ANTI-INFECTIVE MEDICINES

6.1.1 Intestinal anthelminthics

4572

Albendazole

Chewable tablet


OPD

73 Suspension200 mg/5 ml


OPD

6.1.2 Antifilarials46 74 Ivermectin Tablet 6 mg GH OPD

6.2 Antibacterial

6.2.1 Beta Lactam medicines

47

75

Amoxicillin

Capsule (anhydrous)

250 mg, GH CHC PHC OPD

76Capsule (anhydrous)


77

Dispersible Tablet


4878

Amoxicillin +


GH CHC OPD

79 Injection 1gm + 200 GH CHC IPD

Page 19

clavulanic acid

mg

80 Injection250 mg + 50 mg

GH CHC IPD

81 Injection500 +100 mg

GH IPD

82Dispersible Tablet

200 mg +28.5 mg

GH CHC OPD

49 83 AmpicillinInjection powder (sodium)

500 mg GH CHC PHC IPD

50

84 Benzathine penicillin

Injection powder (penicillin)

6 lacs IU vial

GH IPD

85Injection powder

12 lacs IU vial

GH IPD

86Injection powder

24 lacs IU vial

GH IPD

51

87

Cefixime

Tablet 100 mg GH CHC PHC OPD 88 Tablet 200 mg GH CHC PHC OPD



52

90

Cefadroxil


OPD

91 Tablet 500 mg GH CHC PHCSub centre

OPD

92 Syrup125mg/ 5 ml,30ml


OPD

93 Drops100 mg/ ml

GH OPD

6.2.1 Beta Lactam Medicines(Complementary)

5394

Cefotaxime Injection 250mg GH CHC PHC IPD

95 Injection 1 gm GH CHC PHC IPD 96 Injection 500 mg GH IPD

54

97 Ceftriaxone Powder (sodium)

Injection powder 250 mg GH CHC PHC IPD

98Injection powder 1 g vial GH CHC PHC IPD

6.2.2 Other antibacterial

55 99 Amikacin Injection 100 mg,/2 ml

GH CHC PHC IPD

Page 20

100 Injection500 mg/2 ml

GH CHC PHC IPD

101 Injection250 mg/2 ml

GH CHC PHC IPD

56

102 Azithromycin

Tablet 250 mg GH CHC PHC OPD 103 Tablet 500 mg GH CHC PHC OPD 104 Tablet 1 gm GH OPD

105 Suspension200 mg/5 ml,15ml

GH CHC PHC OPD

57 106 Levofloxacin


58 107

Ofloxacin* To be used rationally so as to retain its senstivity as antitubercular agent.


59

108 Ciprofloxacin Final selection depends on indication for use

Tablet (hydrochloride)


109Tablet (hydrochloride)


110 Injection IV200 mg/ 100 ml

GH CHC PHC IPD

60 111

Ciprofloxacin +Tinidazole


GH CHC PHC OPD

61 112Doxycycline

Capsule (hydrochloride)


62

113Erythromycin Base


114Oral suspension powder

125 mg/5 ml,30ml

GH OPD

63 115 Gentamycin

Injection (sulphate)

40 mg/ ml, 2 ml vial

GH CHC PHC IPD

64 116 Metronidazole

Tablet 200 mg GH CHC PHC Sub centre

OPD

Page 21

117 Tablet 400 mg GH CHC PHCSub centre

OPD

118 Injection500 mg/ 100ml

GH CHC PHC IPD

119 Suspension200 mg/50 ml

GH CHC PHC OPD

65

120Sulfamethoxazole + trimethoprim (Cotrimoxazole)

Tablet100 mg +20 mg


OPD

121 Tablet800 mg + 160 mg

GH CHC PHC OPD

6.3 Antifungal medicines

66

122Clotrimazole

Pessaries 200 mg GH CHC PHCSub centre

OPD

123 Cream 2%,30 gm GH CHC PHC OPD

124 Solution1% w/v,15ml

GH CHC PHC OPD

67

125

Fluconazole

Capsule/Tablet


126Capsule/Tablet

200mg GH OPD


50 mg GH OPD

6.4 Antiviral medicines(Antiherpes medicines)

68128

AcyclovirTablet 200 mg GH CHC PHC OPD


6.5 Antiprotozoal medicines

69 130 Tinidazole Tablet 500 mg GH CHC PHC OPD 7. ANTIMIGRAINE MEDICINES FOR ACUTE ATTACK

70 131Flunarazine

Tablet 10 mg GH OPD

8. ANTIPARKINSONISM MEDICINES

71 132Trihexyphenidyl


2 mg GH OPD

9. MEDICINES AFFECTING THE BLOOD 9.1 Antianaemia medicines72 133 Ferrous

saltTablet Equivalent

to 100 mg elemental iron

GH OPD

Page 22

134Ferrous salt (sulphate)

Oral solution Equivalent to 25 mg iron /ml

GH OPD

135Ferrous salt (Iron sucrose)

Injection 20mg/ml GH IPD

136

Ferrous salt (Iron sorbitol citric acid complex)

Injection100 mg/ ml

GH IPD

73

137

Ferrous sulphate + Folic acid

Tablet

Equivalent to 60 mg iron + 400 mcg folic acid


OPD

138 Tablet Large



OPD

139Tablet Medium



OPD

140 Tablet Small



OPD

141 Syrup

Equivalent to 100 mg elemental iron + 500 mcg folic acid per 5 ml


OPD

142 Drops GH OPD

74 143 Folic acid Tablet 5mg GH CHC PHCSub centre

OPD

9.2 Medicines affecting coagulation

75144

Ethamsylate

Tablet 500 mg GH CHC PHC OPD 145 Tablet 250 mg GH CHC PHC OPD 146 Injection 250 mg/2 GH CHC PHC IPD

Page 23

ml 9.2 Medicines affecting Coagulation(Complementary)

76 147LMW Heparin

Injection (LMW)

GH IPD

77

148Menadion Sodium Bisulphite

Injection

10 mg/ml, 1 ml ampoule,


IPD

149

1 mg/0.5 ml water based single dose

GH CHC PHC IPD

78 150

Purified Freeze – Dried Human Coagulation Factor VIII, Virus inactivated

Injection 250 IU GH IPD OT

10. BLOOD PRODUCTS AND PLASMA SUBSTITUTES

79 151Plasma Volume Expander

Injection 500ml GH CHC PHCSub centre

IPD

11. CARDIOVASCULAR MEDICINES 11.1 Antianginal medicines80 152 Atenolol Tablet 50 mg GH CHC PHC OPD

81153

DiltiazemTablet 30 mg GH OPD

154 Tablet 60 mg GH OPD 155 Injection 5 mg/ml GH IPD

82

156

Glycerine trinitrate

Tablet (sublingual)

500 micrograms

GH CHC PHC IPD

157Glycerine trinitrate SR

0.5 mg GH IPD

158Injection (Nitro Glycerine)

5 mg/ ml GH IPD

83159 Isosorbide

mononitrate

Tablet 5 mg GH CHC PHC IPD

160 Tablet 20 mg (SR) GH CHC PHC IPD

84 161Isosorbide dinitrate

Tablet (sublingual)

5 mg GH CHC PHC IPD

85162

MetoprololTablet 25 mg GH CHC PHC OPD


Page 24

86 164 Carvediolol Tablet 3.125 mg GH OPD 11.2 Antiarrhythmic medicines

87 165 Adenosine (Phosphate)

Injection 3 mg/ ml GH IPD

88 166 Digoxin Tablet 0.25 mg GH CHC OPD 11.3 Antihypertensive medicines

89167

AmlodipineTablet 5 mg GH CHC PHC OPD


90 169 Enalapril Maleate


91 170Hydrochlorothiazide


92 171Methyldopa


93 172Losartan HCL


94 173 Nifedipine Tablet (SR) 20 mg GH OPD

95174

Ramipril Tablet 2.5 mg GH OPD

175 Tablet 5 mg GH OPD 96 176 Labetalol Tablet 100 mg GH CHC OPD

97 177Telmisartan HCL

Tablet 40mg GH OPD

Methyldopa & Labetalol is listed for use in the management of pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.

11.5 Antithrombotic medicines

98178 Acetylsalic

ylic acidTablet 75 mg GH CHC PHC OPD

179 Tablet 150 mg GH CHC PHC OPD 99 180 Clopidogrel Tablet 75 mg GH CHC OPD 11.6 Thrombolytic

100 181Streptokinase

Injection powder

1500000 IU

GH IPD

101182

Atorvastatin

Tablet10 mg GH CHC PHC OPD

183Tablet


11.7 Anti Fibrinolytic & Presser Agent

102184

Tranexanemic Acid

Injection500 mg/5 ml

GH CHC IPD

185 Tablet 500 mg GH CHC OPD

103 186 Mephentermine

Injection 30 mg/ml GH OT

Page 25

12. DERMATOLOGICAL MEDICINES (topical) 12.1 Antifungal medicines

104 187 Miconazole

Cream (nitrate)

2%,15gm GH CHC PHC OPD

105 188Clindamycin

Cream1% w/w,10gm

GH OPD

12.1 Skin(Complementary)

106 189

Clobetasol + Gentamycin

Ointment0.05% + 0.1 %, 5gm

GH CHC PHC OPD

107 190Permethrin (Only for scabies)

Cream 5%, 30 gm GH CHC PHC OPD

12.2 Anti-infective medicines108 191 Acyclovir Cream 5% GH OPD

109 192Silver sulfadiazine

Cream 1%,250mg GH CHC PHCSub centre

OPD

12.3 Anti-inflammatory and antipruritic medicines

110 193Betamethasone

Cream (Dipropionate)

0.1% GH CHC PHC OPD

111 194Calamine lotion

Lotion 8% GH CHC OPD

112 195 Fluticasone Ointment 0.005% GH OPD 12.4 Medicines affecting skin differentiation and proliferation

113 196Momaetasone Furoate

Lotion 0.1%, 15 ml GH OPD

114 197Fluocinolone Acetonide

Ointment 0.1% GH OPD

115 198 Benzoyl Per Oxide

Gel2.5%, 10 gm GH OPD

12.5 Scabicides and pediculicides

116199 Gamma

Benzene Hexachloride

Lotion 1%, 100 ml GH CHC PHCSub centre

OPD

200 Cream 1%, 25 gm GH CHC PHCSub centre

OPD

13. DISINFECTANTS AND ANTISEPTICS 13.1 Antiseptics

117 201Hydrogen Peroxide

Solution 1% GH CHC PHC OT

118 202 Cetrimide Solution 20% conc. GH CHC PHC OT

Page 26

for dilution

119 203Chlorhexidine

Solution5% conc. for dilution


OT

120

204

Povidone iodine

Solution 5%,500ml, GH CHC PHCSub centre

OT

205 Solution10%, 500 ml

GH OT

206 Solution 5%,5 litre GH CHC PHC OT

207 Ointment 5%,15gm GH CHC PHCSub centre

IPD

208 Ointment 5%,250 gm GH CHC PHCSub centre

OPD

209 Scrub7.5%, 500 ml


IPD

13.1 Antiseptics(Complementary)

121210

FramycetinCream

1%, 100 gm

GH

IPD

211 Cream 1 % 20gm GH CHC PHC OPD 13.2 Disinfectants

122 212 Bleaching powder

Powder GH CHC PHCSub centre

OT

123 213Glutraldehyde

Solution 2% / 2.4% GH CHC IPD

14. MEDICINES FOR UROLOGY 14.1 DIURETICS

124

214Furosemide


215 Injection10 mg/ml 2-ml ampoule

GH CHC PHC IPD

125 216 MannitolInjectable solution

20%, 350 ml

GH CHC IPD

126 217Spironolactone

Tablet 25 mg GH OPD

14.2 Medicines for BPH

127 218Tamsulosin Hydrochloride

Tablet 0.4 mg GH CHC OPD

128 219

Tamsulosin + Dutasteride

Tablet0.4 mg + 0.5 mg

GH OPD

129 220Flavoxate Hydrochloride


Page 27

14.3 Alkalising Solution

130 221Disodium Hydrogen Citrate

Suspension1.38 gm/100 ml

GH CHC PHC OPD

15. GASTROINTESTINAL MEDICINES 15.1 Antacids and other antiulcer medicines

131

222Aluminium hydroxide + magnesium hydroxide + Simethicone

Chewable Tablet

250 mg +250 mg + 25 mg

GH CHC PHC OPD

223Oral suspension

300 mg+ 150 mg+ 40 mg/ 5 ml, 180 ml

GH CHC PHC OPD

132 224

Aluminium hydroxide + magnesium hydroxide + Simethicone + magnesium Carbonate

Chewable Tablet

240 mg+100 mg+25 mg +60 mg

GH CHC PHC OPD

133 225Omeprazole

Capsule 20 mg GH CHC PHC OPD

134

226

Ranitidine

Tablet (HCL) 150 mg GH CHC PHCSub centre

OPD

227 Injection25 mg/ml in 2-ml amp

GH CHC PHC IPD

15.2 Antiemetic medicines

135228

Domperidone


OPD

229 Suspension1 mg/ ml, 30ml


OPD

136 230 Cinnarizine Tablet 25 mg GH CHC PHC OPD

137

231 Metoclopramide

Tablet (Hydrochloride)


232Injection (hydrochloride)

5 mg/ ml in 2-ml amp

GH CHC PHC IPD

138 233 Tablet 5 mg GH CHC PHC OPD

Page 28

234 Injection 12.5 mg/ml GH IPD

139

235 Ondansetron

Tablet 4 mg GH CHC PHC IPD 236 Tablet 8 mg GH CHC PHC IPD

237 Injection2 mg/ ml 2ml ampoule

GH CHC PHC IPD

140

238

Promethazine



239Elixir or syrup (hcl)

5 mg/ 5 ml GH CHC PHC OPD

240Injection (hydrochloride)

25 mg/ml in 2-ml amp

GH CHC PHC IPD

141 241 Doxylamine succinate


15.3 Antihaemorrhoidal medicines

142 242

Local anaesthetic, astringent and anti-inflammatory medicines

Ointment or suppository

GH CHC PHC OPD

15.4 Antispasmodic medicines

143 243Dicyclomine



OPD

144 244

Mephenamic Acid + Dicyclomine

Tablet500 mg +20 mg

GH CHC PHC OPD

145245

Drotaverine


246 Injection40 mg/ 2 ml

GH CHC PHC IPD

146247 Hyoscine

butyl bromide


248 Injection 20 mg/ ml GH CHC PHC IPD

15.5 Laxatives147 249 Bisacodyl Tablet 5 mg GH CHC PHC OPD 148 250 Milk of

Magnesia +Liquid

Suspension 11.25 ml + 3.75 ml/ 15 ml (50

GH CHC PHC OPD

Page 29

Paraffinml Packing)

15.6 Medicines used in Diarrhoea

149251 Oral

rehydration salts

Powder for solution

As per IP GH CHC PHCSub centre

OPD

252Powder for solution

For 200 ml GH CHC PHCSub centre

OPD

150253

Zinc

Tablet (Sulphate)


OPD

254Suspension (Sulphate)

20 mg/5 ml


OPD

16. HORMONES 16.1 Insulins and other antidiabetic

151 255Glibenclamide


152 256 Glimipride Tablet 1 mg GH CHC OPD

153257

* GliclazideTablet 40 mg GH CHC OPD

258 Tablet 80 mg GH CHC OPD

154 259

Biphasic Isophane (R-DNA origin 30/70

Injection 40 I.U/ml GH IPD

155 260 Insulin (soluble)

Injection40 IU/ml in 10 ml vial

GH IPD

156 261

Intermediate-acting insulin (Lente)

Injection40 IU/ml in 10 ml vial

GH IPD

157

262

Metformin



263Tablet (hydrochloride)

1 gm SR GH OPD

16.2 Ovulation inducers

158 264 ClomifeneTablet (citrate)

50 mg GH OPD

16.3 Progestogens

159 265Medroxyprogesterone acetate

Tablet 10mg GH OPD

160 266Progesterone


Page 30

161 267 Norethisterone

Tablet 5 mg GH OPD

16.4 Thyroid hormones and antithyroid medicines

162 268Levothyroxine

Tablet (sodium)

50 mcg GH CHC PHC OPD

163 269Carbimazole

Tablet 5 mg GH OPD

17. IMMUNOLOGICALS 17.1 Diagnostic agents All tuberculins should comply with the WHO Requirements

164 270

Tuberculin, purified protein derivative (PPD)

Injection2 T.U./0.1 ml

GH IPD

17.2 Sera and immunoglobulins

All plasma fractions should comply with the WHO Requirements for the Collection, Processing and Quality Control of Blood, Blood Components and Plasma Derivatives.

165

271Anti-RHO-D Immunoglobulin(Human) Injection (Polyclonal) (Thiomersal Free)

Injection50 mcg / vial

GH CHC PHC IPD

272 Injection150 mcg/vial

GH IPD

273 Injection300mcg/vial

GH CHC PHC IPD

17.3 For specific groups of individuals

166 274Tetanus vaccine

Injection0.5 ml Ampoule


IPD

167 275 Hepatitis B vaccine

Injection1 % vial, 10 mg/ml, 10 ml vial


IPD

168

276 Anti Rabies vaccine (Chick-Embryo/Verocell/Human Diploid)

Injection ID 1 ml GH CHC PHC IPD

277 Injection IM 0.5 ml GH CHC PHC IPD

18. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS

169 278 Injection 10 mg/ ml GH OT

Page 31

Atracurium besylate

170 279Succinyl Choline Vial

Injection 50 mg/ml GH OT

171 280Neostigmine (methyl)

Injection 500 mcg/ ml in 1 ml amp

GH OT

19. OPHTHALMOLOGICAL PREPARATIONS 19.1 Anti-infective agents

172 281Chloramphenicol

Ointment 1% GH CHC PHCSub centre

OPD

173282 Ciprofloxac

inDrops 0.3% GH CHC PHC

Sub centre

OPD

283 Ointment 0.3% GH OPD

174 284

Ciprofloxacin + Dexamethasone

Eye Drops0.3% +0.1%

GH OPD

175 285Tobramycin

Eye drops0.3%w/v, 5 ml

GH OPD

176 286Moxifloxacin

Eye drops0.5%w/v, 5 ml

GH OPD

19.3 Anti-inflammatory agents

177 287

Prednisolone (sodium phosphate)

Eye drops 1% GH OPD

178 288Flurbiprofen

Eye Drop 0.03% GH OPD

179 289Flouromethalone

Eye drops 0.1% w/v GH OPD

19.5 Miotics and antiglaucoma medicines

180 290 Acetazolamide


181 291

Pilocarpine (hydrochloride or nitrate)

Eye drops 2% GH OPD

182292 Timolol

(maleate)Eye drops

0.25% , 5 ml

GH OPD

293 Eye drops 0.5%, 5 ml GH OPD 19.6 Mydriatics

Page 32

183 294Cyclopentolate

Eye Drop 1% w/w GH IPD

184 295

Tropicamide + Phenylepherine

Eye Drops 0.8% + 5% GH IPD

19.7 Lubricating

185 296

Hydroxypropyl mehtylcellulose

Injection 2% GH IPD

19.8 Anti Allergic

186 297Anti Allergic

Eye Drops GH CHC PHC OPD

187 298Disodium Cromoglycate

Eye Drops GH CHC PHC OPD

20. NASAL ENT

188299

Xylometazoline

Drops 0.05%, GH CHC PHC OPD

300 Drops 0.1% GH CHC PHC OPD

189 301 Saline Nasal Drops 0.6% GH CHC PHCSub centre

OPD

190 302 Glycerin Solution500 gm bottle

GH CHC PHC OPD

191 303

Paradichlorbenzene + Benzocain + Chlorbutol + Turpentine Oil

Ear Drops2 % + 2.7 % + 5 % + 15 %

GH CHC PHC OPD

192 304

Chloremphenicol +Beclomethasone dipropoinate +Clotrimazole + lignocaine Hydrochloride HCL

Ear Drops

5 % w/v + 0.025% w/v + 1 % w/v + 2 % w/v

GH CHC PHC OPD

Page 33

193 305Clotrimazole

Ear Drops GH CHC PHC OPD

21. OXYTOCICS AND ANTIOXYTOCICS 21.1 Oxytocics

194

306 Methyl ergometrine

Tablet 125 mcg GH CHC PHCSub centre

OPD

307 Injection 200 mcg in 1 ml ampoule


IPD

195 308 Oxytocin Injection5 IU in 1 ml ampoule


IPD

21.1 Oxytocics (Complementary)196 309 Carboprost Injection 25

mg/ml(250 mcg)

GH IPD

197 310Dinoprostone

Gel0.5 mg, 3 gm

GH IPD

198 311Mifepristone


199312

Misoprostol

Tablet 25 mcg GH IPD

313 Tablet 200 mcg GH CHC PHCSub centre

IPD

21.2 Antioxytocics

200

314 Isoxsuprine (hydrochloride)


315 Injection 5 mg/ ml GH CHC PHC IPD

201 316Valethemate

Injection 8mg/ml GH CHC PHC IPD

22. PSYCHOTHERAPEUTIC MEDICINES 22.1 Medicines used in psychotic disorders

202 317

Chlorpromazine (hydrochloride)

Tablet 50 mg GH OPD

203 318

Fluphenazine (Decanoate)

Injection25 mg, 1 ml ampoule

GH IPD

204319

Haloperidol

Tablet 5 mg GH OPD

320 Injection5 mg , 1 ml ampoule

GH IPD

205 321Risperidone

Tablet 2gm GH OPD

Page 34

206 322 Quetiapine Tablet SR 50 mg GH OPD 22.2 Medicines used in depressive disorders

207 323

Amitriptyline (hydrochloride)


208 324Fluoxetine (hydrochloride)

Capsule 20 mg GH CHC PHC OPD

209 325 Sertraline Tablet (SR) 50 mg GH OPD 22.3 Medicines used in bipolar disorders

210 326Lithium carbonate


22.4 Medicines used in generalized anxiety and sleep disorders

211327

AlprazolamTablet 0.25 mg GH CHC PHC OPD

328 Tablet 0.5 mg GH CHC PHC OPD 212 329 Donepezil Tablet 5 mg GH OPD

213 330Clonazepam

Tablet 0.5mg GH OPD

22.5 Medicines used for Deaddiction 214 331 Bupropion Tablet 150mg GH OPD

215 332Buprenorphine

Tablet (Sublingual)

0.4mg GH OPD

23. MEDICINES ACTING ON THE RESPIRATORY TRACT 23.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease

216 333

Cough Expectorent (Salbutamol 2 mg + Bromhexine 4 mg)

Syrup

Salbutamol 2 mg + Bromhexine 4 mg

GH CHC PHC OPD

217

334

Salbutamol

Inhalation – aerosol

100 micrograms/ dose

GH CHC PHC OPD

335 Suspension 2 mg/5 ml GH CHC PHC OPD

336Nebulizer solution (sulphate)

5 mg/ ml GH CHC PHC IPD

218 337Beclomethasone + Salbutamol

Inhalation (MDI)

GH OPD

219 338 Etophylline

Tablet 115 mg + 35 mg,

GH CHC PHC OPD

Page 35

+ Theophylline

339 Tablet231 mg + 69 mg

GH CHC PHC OPD

340 Injection169.4 mg + 56.6 mg/2 ml

GH CHC PHC IPD

220 341 Budesonide

Nebulizer solution

15 ml vial GH CHC IPD

221342

Salbutamol

Tablet (sulphate)

2 mg GH CHC PHC OPD

343Tablet (sulphate)

4 mg GH CHC PHC OPD

24. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES 24.1 Parenteral

222

344 Glucose/dextrose

Injectable solution

5%, isotonic


IPD

345Injectable solution

10% isotonic

GH IPD

346 Injectable 25% GH IPD

223 347

Glucose with sodium chloride/saline

Injectable solution

5% glucose + 0.9% sodium chloride

GH CHC PHC IPD

224 348 Isolyte – P Injection GH CHC PHC IPD

225 349 Potassium chloride

Injectable solution

11.2% in 20ml

GH IPD

226 350 Ringer lactate

Injectable IV solution


IPD

227 351 Sodium bicarbonate

Injectable IV solution

7.5% GH CHC PHC IPD

228 352Sodium chloride

Injectable solution

0.9% isotonic

GH CHC PHC IPD

24.2 Miscellaneous

229 353Water for injection

Injection5ml ampoule

GH CHC PHC IPD

25. VITAMINS AND MINERALS

230 354Ascorbic acid


231355 Calcium

saltsTablet 500 mg GH CHC PHC

Sub centre

OPD

356 Syrup GH OPD

232 357Pyridoxine HCl

Tablet 10 mg GH OPD

Page 36

233 358 Vitamin A Suspension100000 IU/ml


OPD

234359

Multi Vitamin

Syrup GH CHC PHC OPD 360 Injection GH CHC PHC IPD 361 Drops GH CHC PHC OPD

235 362 B-Complex Tablet GH CHC PHCSub centre

OPD

236

363

Vitamin D

Cholecalciferol sachets

1000 IU GH CHC PHC OPD

364 Drops 4000IU GH CHC PHC OPD

365Tablet (Chewable)

60000 IU GH CHC PHC OPD

26. ANTIMALARIAL MEDICINES (TO BE PROCURED AT STATE LEVEL)237 366 Artesunate Tablet 50 mg GH CHC PHC OPD

367 Injection 60 mg/ml GH CHC IPD

238 368 Artemether Injection80 mg/ml, 1 ml amp

GH CHC IPD

239369 Chloroquin

e (Phosphate)

Tablet150 mg base

GH CHC PHCSub Centre

OPD

370 Suspension50 mg/ 5 ml

GH CHC OPD

240371 Primaquine

(Diphosphate)

Tablet 2.5 mg GH CHC PHC OPD 372 Tablet 7.5 mg GH CHC PHC OPD 373 Tablet 15 mg GH CHC PHC OPD

241 374Quinine (Dihydrochloride)

Injection300 mg/ ml, 2ml ampoule

GH CHC IPD

242 375

Sulfadoxine + Pyrimethamine


GH CHC PHC OPD

Page 37

Schedule D

Revised Haryana EML( Drugs Approved for Local Purchase)

Total Drugs = 44

Total Components = 52

* All the drugs to be dispensed in OPD will be made available in IPD as and when required.

* All drugs in OPD,IPD should be made available in OT as and when required.

* The column IPD combines the drugs to be made available at different work stations of the hospital like wards,injection room,Labour Room, emergency department,ICU,SNCU,minor OT or any other.

Drugs Sr. No.

Comp.Sr. No.

MedicinesDosage Forms

Strength Category Usage

GH CHCPHC/UD

Sub centre

OPD IPD OT

1. ANAESTHETICS

1.1 General anesthetics and oxygen

1 1Nitrous oxide

Inhalation GH OT

2 2 OxygenInhalation (medicinal gas)


OT

1.2 Local anaesthetics

33 Lignocaine

Hydrochloride

Injection ( Heavy)

2%, 2 ml vial

GH CHC OT

4 Injection4%, 30 ml vial

GH OT

2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS IN RHEUMATOID DISORDERS (DMARDs)

2.3 Medicines used to treat gout

4 5 Allopurinol Tablet 100 mg GH CHC PHC OPD

3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS

Page 38

5 6Methyl Prednisolone

Injection 1 gm vial GH IPD

6 7 Adrenaline Injection

1 mg/ml (1:1000) ( 1 ml ampoule)

GH CHC PHC IPD

4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING

4.1 Non-specific

78

Charcoal activated

Tablet 250 mgGH IPD

9 Tablet 500 mgGH IPD

4.2 Specific

8 10 Calcium gluconate

Injection

100 mg/ml, 10 ml amp

GH CHC IPD

9 11 NaloxoneInjection (hydrochloride)

400 mcg,1ml ampoule

GH IPD

10 12Pralidoxime (PAM)

Injection 1 gm vial GH CHC IPD

4.2 Specific (Complementary)

11 13Disodium Edetate

Injection

150 mg/mL ,2ml ampoule

GH IPD

12 14 Penicillamine

Capsule/Tablet

250 mg GH IPD

13 15Deferiprone (Iron Chelator)

Tablet/capsule

250 mg GH IPD

5. ANTICONVULSANTS/ANTIEPILEPTICS

14 16 Clobazam Tablet 10 mg GH OPD

Page 39

6. ANTI-INFECTIVE MEDICINES

6.2.1 Beta Lactam Medicines(Complementary)

1517 Ceftazidime

(pentahydrate)

Injection powder

250 mg GH IPD

18Injection powder

1 g vial GH IPD

6.3 Antifungal medicines

16 19 Griseofulvin Tablet 250 mg GH OPD

8. ANTIPARKINSONISM MEDICINES

1720

Levodopa + Carbidopa


GH OPD

21 Tablet250 mg +25 mg

GH OPD

8. ANTIPARKINSONISM MEDICINES(Complementary)

18 22Bromocriptine

Tablet (mesylate)

2.5 mg GH OPD

9. MEDICINES AFFECTING THE BLOOD

9.2 Medicines affecting coagulation

19 23 Heparin sodium

Injection5000 IU/ ml

GH IPD

2024

Warfarin (sodium)

Tablet 2 mg GH OPD

25 Tablet 5 mg GH OPD

9.2 Medicines affecting Coagulation(Complementary)

21 26

Protamine sulphate (Heparin Antagonist)

Injection

10 mg/ml, 5-ml ampoule

GH IPD

Page 40

11. CARDIOVASCULAR MEDICINES

11.1 Antianginal medicines

2227

PropranololTablet 10 mg GH CHC PHC OPD


11.2 Antiarrhythmic medicines

23 29 Amiodarone Tablet 100 mg GH IPD

24 30 Verapamil Tablet 40 mg GH IPD

11.3 Antihypertensive medicines

25 31 Nifedipine Capsule(Sublingual)

5 mg GH IPD

26 32 Labetolol Injection 20 mg GH IPD

Methyldopa & Labetalol is listed for use in the management of pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.

11.4 Medicines used in heart failure

27 33 Dobutamine Injection125 mg/ 5 ml

GH IPD

28 34 DopamineInjection (hydrochloride)

40 mg/ ml in 5ml Ampoule

GH CHC IPD

12. DERMATOLOGICAL MEDICINES (topical)

12.1 Skin(Complementary)

29 35Trichloroacetic Acid

Crystal GH OT

12.2 Anti-infective medicines

30 36Potassium permangana

Aqueous solution

1 : 10 000 GH CHC PHC IPD

Page 41

te37 Crystal 100 gm GH CHC PHC IPD

14. MEDICINES FOR UROLOGY

14.3 Alkalising(Complementary)

31 38Sodium Bicarbonate

Injection 7.5% GH CHC PHC IPD

15. GASTROINTESTINAL MEDICINES

15.5 Laxatives

32 39Glycerine Saline

Enema GH CHC IPD

16. HORMONES

16.4 Thyroid hormones and antithyroid medicines

33 40Propylthiouracil

Tablet 50 mg GH OPD

17. IMMUNOLOGICALS

17.2 Sera and immunoglobulins

34 41 Anti Rabies Immunoglobulin

Injection3000 IU /ml

GH IPD

18. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS

35 42Vecuronium (bromide powder )

Injection 4 mg Dry Powder/ Ampoule

GH OT

36 43Recronium Bromide

Injection 10 mg/ ml

GH OT

19. OPHTHALMOLOGICAL PREPARATIONS

19.1 Anti-infective agents

37 44 Acylovir Eye Oint 5%, 5 gm GH OPD

Page 42

19.2 Anti Fungal

38 45 Natamycin Eye Drops 2% GH OPD

19.4 Miscellaneous

39 46Hyaluronidase

Injection1500 IU/ ml

GH OT

40 47Tryphen Blue Dye

GH OT

19.6 Mydriatics

41 48 Atropine (sulphate)

Drops 1% GH IPD

49 Ointment 1% GH IPD

42 50Homatropine

Eye Drops 1% GH IPD

23. MEDICINES ACTING ON THE RESPIRATORY TRACT

23.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease

43 51Aminophylline

Injection25 mg/ ml, 10 ml ampoule

GH CHC IPD

44 52 Ipratropium bromide – aerosol

Nebulizing Solution

GH IPD

Page 43

Schedule E

List of Drugs from STG approved for Local Purchase

Sr No. Sub Sr. No. Name of Drug

1 A.1 Tab Nicorandil

2 A.2 Tab Cyclizine

3 A.3 Cap Pancreatin 170 mg

4 A.4 Human Tetanus Immunoglobulin 3000-5000U

5 A.5 Tab Nimodipin

6 A.6 Human Immunoglobulin

7 A.7 Tab Cyclosporin A

8 A.8 Tab Pyridium

9 A.9 Tab Duloxetine

10 A.10 Capsaicin Cream 0.025-0.075%

11 A.11 Tab Sodium & potassium phosphate 1-1.5 mg

12 A.12 Tab Flucytosine

13 A.13 Hydrocortisone enema

14 A.14 Inj. Pancuronium

15 A.15 Inj sodium iodide 1gm

16 A.16 Sodium Poilstyrene sulphonate solution 10%

17 A.17 Inj. Flumazenil

18 A.18 Ethyl alocohol

19 A.19 Inj. Desferrioxamine

20 A.20 Inj Thiamine

21 A.21 Inj. Pyridoxin

Page 44

22 A.22 Syrup Ipecac

23 A.23 Inj. Fomipezole

24 A.24 Inj Paraldehyde

25 A.25 Sodium thiosulphate 25% solution

26 A.26 Sodium nitrite 3% soln

27 A.27 Inj. Methylene blue

28 A.28 Inj. Physostigmine 0.56 mg

29 A.29 N-acetyl cysteine oral

30 A.30Zinc oxide paste (Petroleum jelly 50%, zinc oxide 50%)

31 A.31 Hydrocortisone -17 butyrate ointment or cream

32 A.32 Salicyclic acid 3 %

33 A.33 Silver nitrate sol 0.25%

34 A.34 Retinoic acid Cream/Gel 0.25%

35 A.35 Intralesional Triamcinolone 10mg/ml

36 A.36 Intralesional Triamcinolone acetonide injections

37 A.37 Halcinoide ointment

38 A.38 Tar (6% in white vaseline) topical solution

39 A.39Modified kligman formula contain Hydrocortisone 1`%, Hydroquinone 2%, Tretinoin 0.025 %

40 A.40 Hydroquinone cream/lotion 5%

41 A.41 Glycolic acid cream 6-12%

42 A.42 Topical psoralen photochemotherapy

43 A.43 Tab. Methoxsalen 10 mg

Page 45

44 A.44 Nephazolin Eye drop

45 A.45 Chlormycetin Eye drop

46 A.46 Dexamethasone eyedrops 0.01%

47 A.47 Natamycin 5% suspension

48 A.48 Acyclovir 3% Eye Ointment

49 A.49 Tab Mementin HCL

50 A.50 Tab Naloxone

51 A.51 Tab Sildenafil

52 A.52 Inj Testosterone Enanthate

53 A.53 Tab Disulfiram

54 A.54 Tab Naltrexaone

55 A.55 Tab Acamprosate

56 A.56 Tab Tibolone

57 A.57 Tab Colchicine

58 A.58 Tab Risedronate 5 mg

59 A.59 Tab Risedronate 35 mg

60 A.60 Diazepam Rectal liquid

61 A.61 Calcium gluconate 10% solution

62 A.62 10 % Ichthamol in glycerin soaked wick pack

63 A.63

Antibiotic steroid wick pack (Polymyxin B sulphate 500 IU, Neomycin sulphate 3400 IU,Zinc bacitracin 400 IU, HydrocORtisone 10 mg/g)

64 A.64 Tab Ambroxol 75mg

65 A.65 Syrup Ambroxol

66 A.66 Tab Mefloquine

Page 46

67 A.67 Tab Osltamivir

68 A.68 Syp. Osltamivir 12 mg /ml

69 A.69 Tab Clarithromycin

70 A.70 Tab Pyrimethamine + Tab Sulphadiazine

71 A.71 Inj Penicillin G

72 A.72 Tab Quinine

73 A.73 Inj Cloxacillin

74 A.74 Inj Acyclovir

75 A.75 Inj Pentamidine Isoethionate

76 A.76 Inj. Nafcillin

77 A.77 Inj Clindamycin

78 A.78 Inj Benzathin Benzylpencillin

79 A.79 Inj. Cefoxitin

B. List of Drugs from STG having alternative in Haryana EML

Sr. No. Sub Sr. No. Drug Name

80 B. 1 Tablet Betahistine 8 mg

81 B. 2 Tablet Betahistine 16 mg

82 B. 3 Inj. Fosphenytoin

83 B. 4 Inj. sodium valporate

84 B. 5 Terbutaline by aerosol Inhale

85 B. 6 1% Silver nitrate cream

86 B. 7 Hartman solution

87 B. 8 Tab Frusemide 20 mg+ Spironolactone 50

88 B. 9 Tab Benzthiazide 25 mg + Triamterene 50 mg

Page 47

89 B. 10 Tab Idapamide

90 B. 11 Tab Lisinopril

91 B. 12 Tab Prazosin

92 B. 13 Tab Clonidine

93 B. 14 Inj. Nitroprusside

94 B. 15 Inj Hydralazine

95 B. 16 Inj phentolamine

96 B. 17 Inj Digoxin (Rapid digitilization)

97 B. 18 Inj. Verapamil

98 B. 19 Inj. Metoprolol

99 B. 20 Inj. Erythromycin

100 B. 21 CapTetracycline

101 B. 22 Hydrocortisone pellets

102 B. 23 Tab Mosapride

103 B. 24 Cap Lansoprazole

104 B. 25 Tab Pentoprazole 20mg

105 B. 26 Tab Pentoprazole 40 mg

106 B. 27 Magnesium sulphate suspension

107 B. 28 Tab Sodium picosulphate

108 B. 29 Isotonic polyethylene glycol (PEG) soln

109 B. 30 Tab Mebavaerine hcl

110 B. 31 Tab Propanthaline hcl

111 B. 32 Tab Mesalazine

112 B. 33 Tab Osalazine

Page 48

113 B. 34 Tab Atovaquone

114 B. 35 Tab Ergotamine

115 B. 36 Tab Ergotamine(1 mg) + Caffeine (100 mg)

116 B. 37 Suppositary Ergotamine(2 mg) + Caffeine (100 mg)

117 B. 38 Tab Sumatriptan

118 B. 39 Inj Sumatriptan

119 B. 40 Tab Topiramate

120 B. 41 Inj. Meropenam

121 B. 42 Glycerol soln

122 B. 43 Tab Rivastigmine

123 B. 44 Tab Pramipixol

124 B. 45 Tab Ropinirole

125 B. 46 Tab Peribidil

126 B. 47 Tab Captopril

127 B. 48 Tab Chlorambucil

128 B. 49 Tab Gabapentin 600 mg

129 B. 50 Tab Gabapentin 75 mg

130 B. 51 Tab Pregabalin 75mg

131 B. 52 Tab Pregabalin 150 mg

132 B. 53 Tab Levocetrizine

133 B. 54 Tab Fexofenadine Hcl 120mg

134 B. 55 Tab Pheniramine Maleate

135 B. 56 Betamethasone nasal drop or

136 B. 57 Budenoside intranasal spray or

Page 49

137 B. 58 Tab Betamethasone

138 B. 59 Eye drop Chloramphenicol 1%

139 B. 60 Eye ointment Tetracycline HCL

140 B. 61 Eye drop/ointment Norfloxacin

141 B. 62 Eye drop Olopatadine

142 B. 63 Betaxolol E/D

143 B. 64 Travoprost E/D

144 B. 65 Dorzolamide E/D

145 B. 66 Brimonidine tartrate E/D

146 B. 67 Cefazolin E/D

147 B. 68 Ofloxacin E/D

148 B. 69 Ketoconazole E/D

149 B. 70 Ganciclovir E/D

150 B. 71 Tab Terbinafine

151 B. 72 Cream 1% Ciclopirox

152 B. 73 Cap Itraconazole

153 B. 74 Gel Benzyl peroxide

154 B. 75 Tab Minocycline

155 B. 76 Tab Famcyclovir

156 B. 77 Tab Evening primrose oil

157 B. 78 Tab Trifluoperazine

158 B. 79 Tab Mirtazapine

159 B. 80 Tab Buspirone

160 B. 81 Tab Fluvoxamine

Page 50

161 B. 82 Tab Zolpidem

162 B. 83 Tab Oxazepam

163 B. 84 Nicotine gum

164 B. 85 Tab Piroxicam

165 B. 86 Tab Febuxostat

166 B. 87 Inj Vitamin A

167 B. 88 Cap .Vitamin A

168 B. 89 Tab Chloramphenicol

169 B. 90 Inj. Chloramphenicol

170 B. 91 Oral Penicillin V

171 B. 92 Inj. Crystalline penicillin

172 B. 93 Inj. Pentamidine

173 B. 94 Syp Nalidixic acid

Page 51

Documents

olicy/Version 01/16/12/2012 Page No Polict Name: …mmiyharyana.gov.in/Docs/Notifications/Guidelines_for... · Web viewThe Haryana Government/State Health Society has been delegating